Global Certificate in CAR-T Cell Therapy Clinical Development
-- ViewingNowThe Global Certificate in CAR-T Cell Therapy Clinical Development is a comprehensive course designed to equip learners with the essential skills needed to excel in the rapidly evolving field of cell therapy. This course is of paramount importance for healthcare professionals, researchers, and industry experts involved in the development, regulation, and commercialization of CAR-T cell therapies.
4,430+
Students enrolled
GBP £ 140
GBP £ 202
Save 44% with our special offer
ě´ ęłźě ě ëí´
100% ě¨ëźě¸
ě´ëěë íěľ
ęłľě ę°ëĽí ě¸ěŚě
LinkedIn íëĄíě ěśę°
ěëŁęšě§ 2ę°ě
죟 2-3ěę°
ě¸ě ë ěě
ë기 ę¸°ę° ěě
ęłźě ě¸ëśěŹí
⢠Introduction to CAR-T Cell Therapy: Understanding the basics of CAR-T cell therapy, its history, and its mechanism of action.
⢠CAR-T Cell Manufacturing Process: Exploring the steps involved in the manufacturing of CAR-T cells, including leukapheresis, genetic modification, and cell expansion.
⢠Clinical Trials Design for CAR-T Cell Therapy: Learning about the different phases of clinical trials, trial endpoints, and study design considerations specific to CAR-T cell therapy.
⢠Regulatory Landscape for CAR-T Cell Therapy: Understanding the regulatory framework governing CAR-T cell therapy development, including requirements for IND submission, marketing authorization, and post-marketing surveillance.
⢠Patient Selection and Pre-treatment Evaluation: Examining the criteria for patient selection, including disease stage, prior treatments, and comorbidities, as well as the importance of pre-treatment evaluation and risk assessment.
⢠Dosing and Administration of CAR-T Cell Therapy: Investigating the factors that influence dosing, the optimal route of administration, and the management of adverse events such as cytokine release syndrome and neurotoxicity.
⢠Monitoring and Follow-up of CAR-T Cell Therapy: Discussing the importance of long-term follow-up and monitoring for CAR-T cell therapy recipients, including strategies for detecting and managing relapse and late toxicities.
⢠Health Economics and Access to CAR-T Cell Therapy: Exploring the economic considerations of CAR-T cell therapy, including cost-effectiveness analysis, reimbursement strategies, and global access to this innovative treatment.
Note: These units are not listed in any particular order and should not be considered a definitive or exhaustive list.
ę˛˝ë Ľ 경ëĄ
ě í ěęą´
- 죟ě ě ëí 기본 ě´í´
- ěě´ ě¸ě´ ëĽěë
- ěť´í¨í° ë° ě¸í°ëˇ ě ꡟ
- 기본 ěť´í¨í° 기ě
- ęłźě ěëŁě ëí íě
ěŹě ęłľě ěę˛Šě´ íěíě§ ěěľëë¤. ě ꡟěąě ěí´ ě¤ęłë ęłźě .
ęłźě ěí
ě´ ęłźě ě ę˛˝ë Ľ ę°ë°ě ěí ě¤ěŠě ě¸ ě§ěęłź 기ě ě ě ęłľíŠëë¤. ꡸ę˛ě:
- ě¸ě ë°ě 기ę´ě ěí´ ě¸ěŚëě§ ěě
- ęśíě´ ěë 기ę´ě ěí´ ęˇě ëě§ ěě
- ęłľě ě겊ě ëł´ěě
ęłźě ě ěąęłľě ěźëĄ ěëŁí늴 ěëŁ ě¸ěŚě뼟 ë°ę˛ ëŠëë¤.
ě ěŹëë¤ě´ ę˛˝ë Ľě ěí´ ě°ëŚŹëĽź ě ííëę°
댏롰 ëĄëŠ ě¤...
ě죟 돝ë ě§ëʏ
ě˝ě¤ ěę°ëŁ
- 죟 3-4ěę°
- 쥰기 ě¸ěŚě ë°°ěĄ
- ę°ë°Ší ëąëĄ - ě¸ě ë ě§ ěě
- 죟 2-3ěę°
- ě 기 ě¸ěŚě ë°°ěĄ
- ę°ë°Ší ëąëĄ - ě¸ě ë ě§ ěě
- ě 체 ě˝ě¤ ě ꡟ
- ëě§í¸ ě¸ěŚě
- ě˝ě¤ ěëŁ
ęłźě ě ëł´ ë°ę¸°
íěŹëĄ ě§ëś
ě´ ęłźě ě ëšěŠě ě§ëśí기 ěí´ íěŹëĽź ěí ě˛ęľŹě뼟 ěě˛íě¸ě.
ě˛ęľŹěëĄ ę˛°ě ę˛˝ë Ľ ě¸ěŚě íë